关注
Dimitrios Laurin Wagner
Dimitrios Laurin Wagner
其他姓名Dimitrios Wagner
Baylor College of Medicine & Charité
在 bcm.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies
D Gomes-Silva, M Srinivasan, S Sharma, CM Lee, DL Wagner, TH Davis, ...
Blood 130 (3), 285-296, 2017
3842017
High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
DL Wagner, L Amini, DJ Wendering, LM Burkhardt, L Akyüz, P Reinke, ...
Nature Medicine, 1, 2018
3812018
Highly efficient genome editing of murine and human hematopoietic progenitor cells by CRISPR/Cas9
MC Gundry, L Brunetti, A Lin, AE Mayle, A Kitano, D Wagner, JI Hsu, ...
Cell reports 17 (5), 1453-1461, 2016
2812016
Constitutive signaling from an engineered IL7 receptor promotes durable tumor elimination by tumor-redirected T cells
T Shum, B Omer, H Tashiro, RL Kruse, DL Wagner, K Parikh, Z Yi, ...
Cancer discovery 7 (11), 1238-1247, 2017
2512017
Immunogenicity of CAR T cells in cancer therapy
DL Wagner, E Fritsche, MA Pulsipher, N Ahmed, M Hamieh, M Hegde, ...
Nature Reviews Clinical Oncology 18 (6), 379-393, 2021
1812021
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression
K Fousek, J Watanabe, SK Joseph, A George, X An, TT Byrd, JS Morris, ...
Leukemia 35 (1), 75-89, 2021
1472021
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial
A Roemhild, NM Otto, G Moll, M Abou-El-Enein, D Kaiser, G Bold, ...
bmj 371, 2020
1462020
Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours
CL Flugel, RG Majzner, G Krenciute, G Dotti, SR Riddell, DL Wagner, ...
Nature Reviews Clinical Oncology 20 (1), 49-62, 2023
1432023
PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia
L Bastian, MP Schroeder, C Eckert, C Schlee, JO Tanchez, S Kämpf, ...
Leukemia 33 (8), 1895-1909, 2019
582019
Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells
J Kath, W Du, A Pruene, T Braun, B Thommandru, R Turk, ML Sturgeon, ...
Molecular Therapy-Methods & Clinical Development 25, 311-330, 2022
45*2022
Cas9-directed immune tolerance in humans—a model to evaluate regulatory T cells in gene therapy?
DL Wagner, L Peter, M Schmueck-Henneresse
Gene therapy 28 (9), 549-559, 2021
392021
Super-Treg: toward a new era of adoptive Treg therapy enabled by genetic modifications
L Amini, J Greig, M Schmueck-Henneresse, HD Volk, S Bézie, P Reinke, ...
Frontiers in Immunology 11, 611638, 2021
382021
CRISPR-Cas9-edited tacrolimus-resistant antiviral T cells for advanced adoptive immunotherapy in transplant recipients
L Amini, DL Wagner, U Rössler, G Zarrinrad, LF Wagner, T Vollmer, ...
Molecular Therapy 29 (1), 32-46, 2021
372021
sustainable clinical development of CAR-T cells–switching from viral transduction towards CRISPR-Cas gene editing
DL Wagner, U Koehl, M Chmielewski, C Scheid, R Stripecke
Frontiers in Immunology 13, 865424, 2022
322022
Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells
V Glaser, C Flugel, J Kath, W Du, V Drosdek, C Franke, M Stein, A Pruß, ...
Genome Biology 24 (1), 89, 2023
182023
Daratumumab for the treatment of refractory ANCA-associated vasculitis
L Ostendorf, M Burns, DL Wagner, P Enghard, K Amann, H Mei, ...
RMD open 9 (1), e002742, 2023
172023
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients
L Peter, DJ Wendering, S Schlickeiser, H Hoffmann, R Noster, DL Wagner, ...
Molecular Therapy-Methods & Clinical Development 25, 52-73, 2022
152022
Central memory phenotype drives success of checkpoint inhibition in combination with CAR T cells
K Toews, L Grunewald, S Schwiebert, A Klaus, A Winkler, S Ali, F Zirngibl, ...
Molecular Carcinogenesis 59 (7), 724-735, 2020
122020
Barring the gates to the battleground: DDR1 promotes immune exclusion in solid tumors
DL Wagner, E Klotzsch
Signal Transduction and Targeted Therapy 7 (1), 17, 2022
72022
Non-viral TRAC-knocked-in CD19KICAR-T and gp350KICAR-T cells tested against Burkitt lymphomas with type 1 or 2 EBV infection: In vivo cellular dynamics and potency
T Braun, A Pruene, M Darguzyte, AF Vom Stein, PH Nguyen, DL Wagner, ...
Frontiers in Immunology 14, 1086433, 2023
52023
系统目前无法执行此操作,请稍后再试。
文章 1–20